BRPI0507233A - processo de produção de polipeptìdeo heterólogo em e.coli - Google Patents

processo de produção de polipeptìdeo heterólogo em e.coli

Info

Publication number
BRPI0507233A
BRPI0507233A BRPI0507233-6A BRPI0507233A BRPI0507233A BR PI0507233 A BRPI0507233 A BR PI0507233A BR PI0507233 A BRPI0507233 A BR PI0507233A BR PI0507233 A BRPI0507233 A BR PI0507233A
Authority
BR
Brazil
Prior art keywords
coli
production process
polypeptide
heterologous polypeptide
polypeptide production
Prior art date
Application number
BRPI0507233-6A
Other languages
English (en)
Inventor
Susan Leung Woon-Lam
James R Swartz
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of BRPI0507233A publication Critical patent/BRPI0507233A/pt
Publication of BRPI0507233B1 publication Critical patent/BRPI0507233B1/pt
Publication of BRPI0507233B8 publication Critical patent/BRPI0507233B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/32—Processes using, or culture media containing, lower alkanols, i.e. C1 to C6
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCESSO DE PRODUçãO DE POLIPEPTìDEO HETERóLOGO EM E. COLI é descrito um processo de produção de polipeptídeo heterólogo a E. coli, em que as células de E. coli compreendem ácido nucléico codificador do polipeptídeo são cultivadas em meio de cultivo mediante alimentação ao meio de cultivo de organofosfato transportável, de tal forma que o ácido nucléico seja expresso. O polipeptídeo é recuperado das células em seguida.
BRPI0507233A 2004-03-11 2005-03-10 processo para a produção de um polipeptídeo heterólogo em e. coli BRPI0507233B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55267804P 2004-03-11 2004-03-11
US60/552,678 2004-03-11
PCT/US2005/007880 WO2005087802A2 (en) 2004-03-11 2005-03-10 Process for producing polypeptides

Publications (3)

Publication Number Publication Date
BRPI0507233A true BRPI0507233A (pt) 2007-06-26
BRPI0507233B1 BRPI0507233B1 (pt) 2018-01-23
BRPI0507233B8 BRPI0507233B8 (pt) 2021-05-25

Family

ID=34976293

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507233A BRPI0507233B8 (pt) 2004-03-11 2005-03-10 processo para a produção de um polipeptídeo heterólogo em e. coli

Country Status (21)

Country Link
US (4) US7294483B2 (pt)
EP (1) EP1733037B1 (pt)
JP (1) JP5014116B2 (pt)
KR (1) KR101210083B1 (pt)
CN (1) CN1954074B (pt)
AU (1) AU2005222397A1 (pt)
BR (1) BRPI0507233B8 (pt)
CA (2) CA2558911C (pt)
DK (1) DK1733037T3 (pt)
ES (1) ES2527291T3 (pt)
HR (1) HRP20150077T1 (pt)
IL (1) IL177488A0 (pt)
ME (1) ME02058B (pt)
NZ (1) NZ549266A (pt)
PL (1) PL1733037T3 (pt)
PT (1) PT1733037E (pt)
RS (1) RS53774B1 (pt)
RU (1) RU2433185C2 (pt)
SI (1) SI1733037T1 (pt)
WO (1) WO2005087802A2 (pt)
ZA (1) ZA200606913B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2433185C2 (ru) * 2004-03-11 2011-11-10 Дженентек, Инк. Способ получения полипептидов
EP1926654B1 (de) * 2005-09-15 2009-12-09 Continental Teves AG & Co. oHG Verfahren und vorrichtung zum lenken eines kraftfahrzeugs
JP2009095237A (ja) 2006-02-02 2009-05-07 Ajinomoto Co Inc Ｌ−アミノ酸の製造法
RU2746407C1 (ru) 2012-02-23 2021-04-13 Стейдж Селл Терапеутикс Гмбх Хроматографическое выделение клеток и других сложных биологических материалов
JP6787894B2 (ja) 2014-12-05 2020-11-18 アレクシオン ファーマシューティカルズ， インコーポレイテッド 組換えアルカリホスファターゼを用いた発作の処置
JP6868561B2 (ja) 2015-01-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼ欠損を有する被験者を治療する方法
JP6993961B2 (ja) * 2015-08-17 2022-01-14 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼの製造
JP7194020B2 (ja) 2015-10-22 2022-12-21 ジュノ セラピューティクス ゲーエムベーハー 細胞の培養方法ならびにそのためのキットおよび装置
US11248238B2 (en) 2015-10-22 2022-02-15 Juno Therapeutics Gmbh Methods, kits, agents and apparatuses for transduction
WO2017074466A1 (en) 2015-10-30 2017-05-04 Alexion Pharmaceuticals, Inc. Methods for treating craniosynostosis in a patient
KR20240160671A (ko) 2016-04-01 2024-11-11 알렉시온 파마슈티칼스, 인코포레이티드 알칼리성 포스파타아제로 근육 약화의 치료
KR20190129058A (ko) 2017-03-31 2019-11-19 알렉시온 파마슈티칼스, 인코포레이티드 성인 및 청소년에서 저포스파타제증 (hpp)을 치료하는 방법
JP7339160B2 (ja) 2017-04-27 2023-09-05 ジュノ セラピューティクス ゲーエムベーハー オリゴマー粒子試薬およびその使用方法
US11913039B2 (en) 2018-03-30 2024-02-27 Alexion Pharmaceuticals, Inc. Method for producing recombinant alkaline phosphatase
ES2972119T3 (es) 2018-08-10 2024-06-11 Alexion Pharma Inc Cicatrización ósea en implantes utilizando fosfatasa alcalina
EP3874024A1 (en) 2018-10-31 2021-09-08 Juno Therapeutics GmbH Methods for selection and stimulation of cells and apparatus for same
KR20220111693A (ko) 2019-12-09 2022-08-09 알렉시온 파마슈티칼스, 인코포레이티드 알칼리성 포스파타제 폴리펩티드 및 이의 이용 방법
US12453805B2 (en) 2020-09-24 2025-10-28 Everest Medical Innovation GmbH Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery
US12426594B2 (en) 2020-09-24 2025-09-30 Everest Medical Innovation GmbH Cryoprotective compositions and methods for protection of a surgical site during cryosurgery
US12083169B2 (en) 2021-02-12 2024-09-10 Alexion Pharmaceuticals, Inc. Alkaline phosphatase polypeptides and methods of use thereof
CN113308393A (zh) * 2021-04-20 2021-08-27 上田环境修复有限公司 一种降解氨氮和总氮的制剂及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304472A (en) * 1992-11-20 1994-04-19 Genentech, Inc. Method of controlling polypeptide production in bacterial cells
US5342763A (en) 1992-11-23 1994-08-30 Genentech, Inc. Method for producing polypeptide via bacterial fermentation
ES2182986T5 (es) * 1995-06-07 2009-03-01 Danisco A/S Hexosa oxidasa recombinante, procedimiento para su produccion y utilizacion de dicha enzima.
AU708239B2 (en) 1995-06-29 1999-07-29 Immunex Corporation Cytokine that induces apoptosis
US6030945A (en) 1996-01-09 2000-02-29 Genentech, Inc. Apo-2 ligand
CA2294704A1 (en) 1997-06-26 1999-01-07 Immunex Corporation Protein that binds trail
RU2139343C1 (ru) * 1997-10-31 1999-10-10 Государственный научный центр прикладной микробиологии Питательная среда для выделения возбудителя геморрагического колита с гемолитико-уремическим синдромом, вызываемого кишечной палочкой 0157:н7 (сорбитол e.coli 0157:н7агар)
JP4707237B2 (ja) 1999-03-17 2011-06-22 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 外因性アミノ酸および新規ａｔｐ再生システムを用いたインビトロ高分子生合成の方法
US6337191B1 (en) * 1999-03-22 2002-01-08 The Board Of Trustees Of The Leland Stanford Junior University Vitro protein synthesis using glycolytic intermediates as an energy source
JP4360758B2 (ja) 1999-04-08 2009-11-11 ジェネンテック・インコーポレーテッド 逆の電荷のポリペプチド類をベースにした組成物
CN101633692A (zh) 1999-06-28 2010-01-27 杰南技术公司 利用二价金属离子制备Apo-2配体的方法
RU2165455C1 (ru) * 1999-11-23 2001-04-20 Государственный научно-исследовательский институт особо чистых биопрепаратов РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pSS5, КОДИРУЮЩАЯ СИНТЕЗ РЕКОМБИНАНТНОГО ЧЕЛОВЕЧЕСКОГО АЛЬФА-2b ИНТЕРФЕРОНА, ШТАММ ESCHERICHIA COLI SS5 - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ЧЕЛОВЕЧЕСКОГО АЛЬФА-2b ИНТЕРФЕРОНА И СПОСОБ ПОЛУЧЕНИЯ ИНТЕРФЕРОНА АЛЬФА-2b
CA2428693A1 (en) 2000-11-14 2002-05-23 The Board Of Trustees Of The Leland Stanford Junior University In vitro protein synthesis using glycolytic intermediates as an energy source
KR100954641B1 (ko) * 2001-09-13 2010-04-27 제넨테크, 인크. 아미노펩티다아제
EP1558631A4 (en) * 2002-10-30 2006-10-04 Pfizer Prod Inc METHOD AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER IN PETS
RU2433185C2 (ru) * 2004-03-11 2011-11-10 Дженентек, Инк. Способ получения полипептидов

Also Published As

Publication number Publication date
HRP20150077T1 (hr) 2015-04-10
CA2946323A1 (en) 2005-09-22
ZA200606913B (en) 2008-03-26
NZ549266A (en) 2008-07-31
EP1733037A2 (en) 2006-12-20
RS53774B1 (sr) 2015-06-30
PT1733037E (pt) 2015-02-05
HK1103761A1 (en) 2007-12-28
ES2527291T3 (es) 2015-01-22
RU2006135933A (ru) 2008-04-20
JP2007537725A (ja) 2007-12-27
AU2005222397A1 (en) 2005-09-22
CA2558911C (en) 2016-12-06
IL177488A0 (en) 2006-12-10
WO2005087802A3 (en) 2006-03-02
US20130236930A1 (en) 2013-09-12
KR20070029144A (ko) 2007-03-13
ME02058B (me) 2015-05-20
US20070026496A1 (en) 2007-02-01
US20050244927A1 (en) 2005-11-03
RU2433185C2 (ru) 2011-11-10
CN1954074B (zh) 2011-08-24
KR101210083B1 (ko) 2012-12-07
CA2558911A1 (en) 2005-09-22
DK1733037T3 (en) 2015-01-12
CN1954074A (zh) 2007-04-25
PL1733037T3 (pl) 2015-04-30
BRPI0507233B1 (pt) 2018-01-23
EP1733037B1 (en) 2014-11-05
JP5014116B2 (ja) 2012-08-29
SI1733037T1 (sl) 2015-02-27
WO2005087802A2 (en) 2005-09-22
US20110059484A1 (en) 2011-03-10
US8389242B2 (en) 2013-03-05
BRPI0507233B8 (pt) 2021-05-25
US7294483B2 (en) 2007-11-13

Similar Documents

Publication Publication Date Title
BRPI0507233A (pt) processo de produção de polipeptìdeo heterólogo em e.coli
WO2016183438A8 (en) Self-targeting genome editing system
MY153731A (en) Recovery of higher alcohols from dilute aqueous solutions
BR112012027282A2 (pt) meio de cultura de células aperfeiçoado
MX2012000251A (es) Recuperacion de alcoholes superiores a partir de soluciones acuosas diluidas.
WO2013082616A3 (en) Compositions and methods for biomass liquefaction
IN2015DN01365A (pt)
UA103335C2 (ru) Способ изготовления добавки для ферментативного расщепления микотоксинов, добавка и ее применение
IN2015DN01606A (pt)
NZ600540A (en) Ethanol production in non-recombinant hosts
AR090949A1 (es) METODO DE USAR a-AMILASA DE ASPERGILLUS CLAVATUS PARA LA SACARIFICACION
WO2010115201A3 (en) Reactor system and method for processing a process fluid
MY156181A (en) Method and system for producing high-purity hydrogen chloride
MX391164B (es) Metodo para producir compuesto opticamente activo
MY184072A (en) Increasing virus like particle yield in plants
WO2008096723A1 (ja) 六フッ化リン酸塩の製造方法
WO2012129962A8 (zh) 一种联合制碱大循环工艺
BR112014030376A2 (pt) processo para a produção de lactato
EA201400192A1 (ru) Клетка, ферментирующая пентозы
EP2480657A4 (en) METHOD FOR EFFICIENT MANUFACTURE OF INDUCED PLURIPOTENTER STEM CELLS
CA2894261C (en) Alpha-amylases and polynucleotides encoding same
ES2168971A1 (es) Procedimiento de produccion de beta-caroteno.
WO2013163292A3 (en) Methods and microorganisms for increasing the biological synthesis of difunctional alkanes
EA200900984A1 (ru) Улучшение клеточного роста
Kim et al. Analysis for energy efficiency of the algae façade-focused on closed bioreactor system

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/03/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2765 DE 02-01-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.